INTS
Income statement / Annual
Last year (2024), Intensity Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Intensity Therapeutics, Inc.'s net income was -$16.27 M.
See Intensity Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$147,000.00
|
$179,037.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
-$147,000.00
|
-$179,037.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$10.50 M
|
$4.79 M
|
$5.13 M
|
$5.86 M
|
$5.05 M
|
$4.44 M
|
| General & Administrative Expenses |
$6.09 M
|
$3.53 M
|
$2.42 M
|
$2.16 M
|
$1.17 M
|
$1.24 M
|
| Selling & Marketing Expenses |
$0.00
|
-$147,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$6.09 M
|
$3.39 M
|
$2.42 M
|
$2.16 M
|
$1.17 M
|
$1.24 M
|
| Other Expenses |
$0.00
|
$0.00
|
$47,646.00
|
$115,513.00
|
$118,757.00
|
$144,989.00
|
| Operating Expenses |
$16.59 M
|
$8.17 M
|
$7.55 M
|
$8.01 M
|
$6.22 M
|
$5.68 M
|
| Cost And Expenses |
$0.00
|
$8.32 M
|
$7.55 M
|
$8.01 M
|
$6.22 M
|
$5.68 M
|
| Interest Income |
$314,000.00
|
$324,000.00
|
$2,481.00
|
$2,609.00
|
$74,009.00
|
$150,707.00
|
| Interest Expense |
$0.00
|
$305,000.00
|
$81,781.00
|
$16,767.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$25,000.00
|
$147,000.00
|
$179,037.00
|
$236,558.00
|
$206,297.00
|
$171,860.00
|
| EBITDA |
-$16.24 M |
-$10.09 M |
-$7.40 M |
-$7.88 M |
-$6.03 M |
-$5.38 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$317,000.00
|
-$2.22 M
|
$49,058.00
|
$118,122.00
|
$192,766.00
|
$295,696.00
|
| Income Before Tax |
-$16.27 M
|
-$10.54 M
|
-$7.58 M
|
-$7.90 M
|
-$6.03 M
|
-$5.38 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$131,908.00
|
-$2,609.00
|
-$74,009.00
|
-$150,707.00
|
| Net Income |
-$16.27 M
|
-$10.54 M
|
-$7.45 M
|
-$7.89 M
|
-$5.96 M
|
-$5.23 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.17 |
-1.38 |
-0.57 |
-0.6 |
-0.45 |
-0.4 |
| EPS Diluted |
-1.17 |
-1.38 |
-0.57 |
-0.6 |
-0.45 |
-0.4 |
| Weighted Average Shares Out |
$13.91 M
|
$8.62 M
|
$13.10 M
|
$13.10 M
|
$13.10 M
|
$13.10 M
|
| Weighted Average Shares Out Diluted |
$13.91 M
|
$8.62 M
|
$13.10 M
|
$13.10 M
|
$13.10 M
|
$13.10 M
|
| Link |
|
|
|
|
|
|
